← Human Trials & Peer-Reviewed Studies
Vitamin D Supplementation and Sunlight Exposure on Serum Vitamin D Concentrations in 2 Parallel, Double-Blind, Randomized, Placebo-Controlled Trials.
Plain-language guide to PMID 34255034 (2021): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 34255034
- Journal
- The Journal of nutrition
- Year
- 2021
- Study type
- Randomized Controlled Trial
- Authors
- Mendes MM et al. (6 authors)
- DOI
- 10.1093/jn/nxab209
- Registered trial
- NCT03318029
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
The researchers aimed to investigate the effects of vitamin D supplementation and sunlight exposure on vitamin D concentrations in Brazilian women living in high compared with low latitudes.
Why It Was Studied
Vitamin D concentrations are a function of sunlight exposure and dietary intake.
However, current dietary vitamin D recommendations do not consider differences in country-specific sunlight availability or spontaneous individual exposure.
Who Took Part
The age groups tagged for this paper are young adults and adults, women only.
In 2 parallel, double-blind, randomized placebo-controlled trials, Brazilian women living in England (51°N) composed "without ultraviolet B (UVB) exposure" groups and those living in Brazil (16°S) composed the "with UVB exposure" groups (mean age, 31.39 ± 8.7 years).
The effects of supplementation and UVB exposure were tested by the intention to treat with a linear mixed model.
How the Study Was Run
The researchers set it up as a randomized, double-blind, placebo-controlled and parallel-group study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
The Vitamin D, K2, Magnesium and Zinc group and the comparison group ran side by side rather than switching.
Serum 25-hydroxyvitamin D [25(OH)D] concentrations, the primary outcome, were assessed by HPLC-MS/MS, vitamin D intakes were assessed by 4-day diet diaries, and sunlight exposure was assessed by UVB dosimeters.
What Was Measured
The subject headings attached to it are Cholecalciferol, Dietary Supplements, Seasons, Sunlight, Tandem Mass Spectrometry, Vitamin D and Vitamin D Deficiency.
The authors tagged it with the keywords Brazil, England, latitude, serum 25(OH)D and supplementation.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2021 (The Journal of nutrition), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.